+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Microbial Fermentation Technology Market Size, Share & Industry Trends Analysis Report by Application, End User, Regional Outlook and Forecast, 2022-2028

  • PDF Icon

    Report

  • 216 Pages
  • March 2023
  • Region: Global
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5778722
Description Jump to:
The Global Microbial Fermentation Technology Market size is expected to reach $42.4 billion by 2028, rising at a market growth of 5.4% CAGR during the forecast period.

Microbial fermentation technologyis novel, promising, and increasing quickly. This fielduses microbes to produce substances with enormous applications in manufacturing biofuels, pharmaceuticals, environmentally friendly materials, fine chemicals, energy,and the food sector. For decades, this technology has been employed in producing highly prized goods. Still, to accomplish the shift to a bio-based society, it is urgently necessary to dramatically speed this technology's development.



Also, there is constant interest in and demand for developing novel microbial fermentation methods for several crucial reasons, including the potential to produce novel compounds and the sustainability element. One of the most crucial elements of contemporary biotechnology is fermentation engineering, which has been widely used in manyfields.

Many techniques, like product and substrate evaluation, microscopy,toxicity tests, or biomass monitoring, help to provide a comprehensive image of the traits and requirements of the strains and allow control over specific fermentation processes. Yeasts are single-cell microorganisms that participate in pulque fermentation by producing ethanol and carbon dioxide while also assisting bacterial growth by creating vitamins, amino acids, and other metabolites.

They also provide the necessary aromatic constituents and proteolytic and lipolytic activities. The processes used to ferment yeast include alcoholic fermentations like beer, wine, and cider fermentation, as well as non-alcoholic yeast fermentations like coffee, bread, and chocolate fermentation. Yeasts are unicellular, eukaryoticmicrofungi found all over the natural world. They are part of the class of organisms known as fungi, which also include mushrooms andmolds.

COVID-19 Impact Analysis

Markets worldwide started focusing onmicrobial strain production technology as it increasedthe output of microbial-based medications. Additionally, the governmentsupports both small and large biotechnology companies in researching vaccinations, medicines, and products that improve gut health and boost immunity. Therefore, the pandemic aided in speeding up the R&D processes associated with the technology. But the closure of industries and disruptions of supply chains prevented the use of technology in any other sector. As a result, the pandemic had a moderate impact on the microbial fermentation technology market.

Market Growth Factors

Increasing demand for alcoholic beverages

Demand for alcoholic beverages has increased in establishments like hotels, restaurants, taverns, and pubs. Every year, wine, spirits, and beer are consumed worldwide in amounts of about 446 billion liters. Beer, lagers, and cider account for about 400 billion liters of all alcohol consumed, with wine and spirits coming in second and third, respectively. Additionally, the industry for alcoholic beverages is predicted to rise due to the growing demand for artisanal spirits in many developing nations. Therefore, as the demand for alcoholic beverages rises, it will propel the demand for microbial fermentation technology, which will ensure the market's growth.

Rising utilization of technology in food enrichment

The amount of protein in mechanically controlled canola meal increased after solid-state fermentation using Pleurotus ostreatus, and the amounts of glucosinolates and phytate decreased by up to 98.8% and 75.8%, respectively. In soybean meal (SBM), solid-state fermentation boosted the amino acid and protein content, with B. subtilis having a bigger influence than A. oryzae. These established experimental results have expanded the use cases for microbial fermentation technology. Hence, the microbial fermentation technology market will expand in the coming years owing to all these factors.

Market Restraining Factor

Issues associated with the fermentation process

Fermented products can be contaminated over time as they undergo continual natural variations. However, contamination through contamination sources is easy even if no variation occurs. Additionally, the product needs more processing because it is impure. The result was unintended and unpleasant; bad germs grew and multiplied while beneficial microbes perished. Some common fermentation processes, like solid state fermentation, have some drawbacks, including using microorganisms that can only withstand low moisture levels and the inability to precisely monitor SSF. Therefore, such difficulties associated with the microbial fermentation processes may hamper the market's growth in the coming years.

Application Outlook

Based on application, the microbial fermentation technology market is categorized into antibiotics, probiotics supplements, monoclonal antibodies, recombinant proteins, biosimilars, vaccines, enzymes, small molecules, and others. The monoclonal antibodies segment procured a considerable growth rate in the microbial fermentation technology market in 2021. One of the most useful biologics for various applications is monoclonal antibodies. These compounds' high binding affinity, selectivity, and specificity often make them advantageous.

End-user Outlook

On the basis of end-user, the microbial fermentation technology market is divided into bio-pharmaceutical companies, contract research organizations (CROs), CMOs & CDMOs, and academic & research institutes. The contract manufacturing organizations (CROs) and contract development & manufacturing organization (CDMOs) segment witnessed the largest revenue share in the microbial fermentation technology market in 2021. CMOs and CDMOs are quickly evolving into the preferred choice for biotherapeutics producers because the majority of the invention in the bioprocess industry is produced by smaller businesses that lack the capacity, skilled personnel, and resources necessary for the development of these products.



Regional Outlook

Region wise, the microbial fermentation technology market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Asia Pacific segment procured the maximum revenue share in the microbial fermentation technology market in 2021. This results from acknowledging Asian nations as a center for outsourcing in the biopharmaceutical industry. An estimated 50% of new bioprocessing facilities worldwide are being built by Asian businesses, including domestic competitors and international powerhouses. For example, China plans to build several bioprocessing facilities to accommodate domestic demand.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Biocon Limited, BioVectra Inc. (H.I.G. Capital, LLC), Danone S.A., F. Hoffmann-La Roche Ltd., Koninklijke DSM N.V., Lonza Group AG, Novozymes A/S (Novo Holdings A/S), Corbion N.V., and Bangalore Biotech Labs Pvt. Ltd. (BiOZEEN).

Recent Strategies Deployed in Microbial Fermentation Technology Market

  • Feb-2023: Danone opened a new Research and Innovation Center in Paris. The new research center would enable the company to develop and innovate fresh dairy and plant-based products and 'natural mineral water' categories.
  • Nov-2022: Biocon took over Viatris, Inc., an American pharmaceutical and healthcare corporation. The acquisition enables the company to emerge as a leading biosimilar player with eight commercialized products. Additionally, it would improve the research and development, global-scale manufacturing, and commercialization abilities of the company.
  • Nov-2022: BioVectra Inc. unveiled single-use fermentation microbial technology. The new technology contains 100 L and 1,000 L single-use fermenters. The single-use fermentation microbial technology would allow the company to provide greater flexibility, faster turnaround times, and increased capacity utilization to its customers.
  • Jul-2022: Novozymes introduced Innova Apex and Innova Turbo. The two new advanced yeasts are intended to break down fermentation bottlenecks and at the same time decrease the demand for urea and improve ethanol yield. The yeasts maximize the fermentation process, thereby enabling ethanol producers to achieve their production targets. The Innova Apex pushes the plant to 36 & dry solids and decreases glycerol by 38%.
  • Sep-2021: BioVectra signed an agreement with ABEC, a customized process solutions and services provider. The integration of ABEC CSR single-use fermentation solutions would enhance BIOVECTRA’s high-growth microbial fermentation processes and would enable the company to offer a turnaround product to product and between batches.
  • Apr-2019: BioVectra Inc. expanded its geographical footprints in Windsor, Canada. The new manufacturing facility enables the company to manufacture substances to be used in developing treatments for cancer, autoimmune diseases, and diabetes.
  • Mar-2019: DSM and Cargill, agricultural, financial, and industrial products provider, together launches Avansya, a producer of produce zero-calorie, great-tasting sweeteners through fermentation. Avansya would produce sweet-tasting molecules, such as steviol glycosides Reb M and Reb D through a fermentation process.

Scope of the Study

By Application

  • Antibiotics
  • Recombinant Proteins
  • Enzymes
  • Monoclonal Antibodies
  • Probiotics Supplements
  • Vaccines
  • Biosimilars
  • Small Molecules
  • Others

By End-user

  • CMOs & CDMOs
  • Bio-Pharmaceutical Companies
  • Contract Research Organizations (CROs)
  • Others

By Geography

  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Biocon Limited
  • BioVectra Inc. (H.I.G. Capital, LLC)
  • Danone S.A.
  • F. Hoffmann-La Roche Ltd.
  • Koninklijke DSM N.V.
  • Lonza Group AG
  • Novozymes A/S (Novo Holdings A/S)
  • Corbion N.V.
  • Bangalore Biotech Labs Pvt. Ltd. (BiOZEEN)

Unique Offerings

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Microbial Fermentation Technology Market, by Application
1.4.2 Global Microbial Fermentation Technology Market, by End-user
1.4.3 Global Microbial Fermentation Technology Market, by Geography
1.5 Research Methodology
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Microbial Fermentation Technology Market
Chapter 4. Global Microbial Fermentation Technology Market by Application
4.1 Global Antibiotics Market by Region
4.2 Global Recombinant Proteins Market by Region
4.3 Global Enzymes Market by Region
4.4 Global Monoclonal Antibodies Market by Region
4.5 Global Probiotics Supplements Market by Region
4.6 Global Vaccines Market by Region
4.7 Global Biosimilars Market by Region
4.8 Global Small Molecules Market by Region
4.9 Global Others Market by Region
Chapter 5. Global Microbial Fermentation Technology Market by End-user
5.1 Global CMOs & CDMOs Market by Region
5.2 Global Bio-Pharmaceutical Companies Market by Region
5.3 Global Contract Research Organizations (CROs) Market by Region
5.4 Global Others Market by Region
Chapter 6. Global Microbial Fermentation Technology Market by Region
6.1 North America Microbial Fermentation Technology Market
6.1.1 North America Microbial Fermentation Technology Market by Application
6.1.1.1 North America Antibiotics Market by Country
6.1.1.2 North America Recombinant Proteins Market by Country
6.1.1.3 North America Enzymes Market by Country
6.1.1.4 North America Monoclonal Antibodies Market by Country
6.1.1.5 North America Probiotics Supplements Market by Country
6.1.1.6 North America Vaccines Market by Country
6.1.1.7 North America Biosimilars Market by Country
6.1.1.8 North America Small Molecules Market by Country
6.1.1.9 North America Others Market by Country
6.1.2 North America Microbial Fermentation Technology Market by End-user
6.1.2.1 North America CMOs & CDMOs Market by Country
6.1.2.2 North America Bio-Pharmaceutical Companies Market by Country
6.1.2.3 North America Contract Research Organizations (CROs) Market by Country
6.1.2.4 North America Others Market by Country
6.1.3 North America Microbial Fermentation Technology Market by Country
6.1.3.1 US Microbial Fermentation Technology Market
6.1.3.1.1 US Microbial Fermentation Technology Market by Application
6.1.3.1.2 US Microbial Fermentation Technology Market by End-user
6.1.3.2 Canada Microbial Fermentation Technology Market
6.1.3.2.1 Canada Microbial Fermentation Technology Market by Application
6.1.3.2.2 Canada Microbial Fermentation Technology Market by End-user
6.1.3.3 Mexico Microbial Fermentation Technology Market
6.1.3.3.1 Mexico Microbial Fermentation Technology Market by Application
6.1.3.3.2 Mexico Microbial Fermentation Technology Market by End-user
6.1.3.4 Rest of North America Microbial Fermentation Technology Market
6.1.3.4.1 Rest of North America Microbial Fermentation Technology Market by Application
6.1.3.4.2 Rest of North America Microbial Fermentation Technology Market by End-user
6.2 Europe Microbial Fermentation Technology Market
6.2.1 Europe Microbial Fermentation Technology Market by Application
6.2.1.1 Europe Antibiotics Market by Country
6.2.1.2 Europe Recombinant Proteins Market by Country
6.2.1.3 Europe Enzymes Market by Country
6.2.1.4 Europe Monoclonal Antibodies Market by Country
6.2.1.5 Europe Probiotics Supplements Market by Country
6.2.1.6 Europe Vaccines Market by Country
6.2.1.7 Europe Biosimilars Market by Country
6.2.1.8 Europe Small Molecules Market by Country
6.2.1.9 Europe Others Market by Country
6.2.2 Europe Microbial Fermentation Technology Market by End-user
6.2.2.1 Europe CMOs & CDMOs Market by Country
6.2.2.2 Europe Bio-Pharmaceutical Companies Market by Country
6.2.2.3 Europe Contract Research Organizations (CROs) Market by Country
6.2.2.4 Europe Others Market by Country
6.2.3 Europe Microbial Fermentation Technology Market by Country
6.2.3.1 Germany Microbial Fermentation Technology Market
6.2.3.1.1 Germany Microbial Fermentation Technology Market by Application
6.2.3.1.2 Germany Microbial Fermentation Technology Market by End-user
6.2.3.2 UK Microbial Fermentation Technology Market
6.2.3.2.1 UK Microbial Fermentation Technology Market by Application
6.2.3.2.2 UK Microbial Fermentation Technology Market by End-user
6.2.3.3 France Microbial Fermentation Technology Market
6.2.3.3.1 France Microbial Fermentation Technology Market by Application
6.2.3.3.2 France Microbial Fermentation Technology Market by End-user
6.2.3.4 Russia Microbial Fermentation Technology Market
6.2.3.4.1 Russia Microbial Fermentation Technology Market by Application
6.2.3.4.2 Russia Microbial Fermentation Technology Market by End-user
6.2.3.5 Spain Microbial Fermentation Technology Market
6.2.3.5.1 Spain Microbial Fermentation Technology Market by Application
6.2.3.5.2 Spain Microbial Fermentation Technology Market by End-user
6.2.3.6 Italy Microbial Fermentation Technology Market
6.2.3.6.1 Italy Microbial Fermentation Technology Market by Application
6.2.3.6.2 Italy Microbial Fermentation Technology Market by End-user
6.2.3.7 Rest of Europe Microbial Fermentation Technology Market
6.2.3.7.1 Rest of Europe Microbial Fermentation Technology Market by Application
6.2.3.7.2 Rest of Europe Microbial Fermentation Technology Market by End-user
6.3 Asia Pacific Microbial Fermentation Technology Market
6.3.1 Asia Pacific Microbial Fermentation Technology Market by Application
6.3.1.1 Asia Pacific Antibiotics Market by Country
6.3.1.2 Asia Pacific Recombinant Proteins Market by Country
6.3.1.3 Asia Pacific Enzymes Market by Country
6.3.1.4 Asia Pacific Monoclonal Antibodies Market by Country
6.3.1.5 Asia Pacific Probiotics Supplements Market by Country
6.3.1.6 Asia Pacific Vaccines Market by Country
6.3.1.7 Asia Pacific Biosimilars Market by Country
6.3.1.8 Asia Pacific Small Molecules Market by Country
6.3.1.9 Asia Pacific Others Market by Country
6.3.2 Asia Pacific Microbial Fermentation Technology Market by End-user
6.3.2.1 Asia Pacific CMOs & CDMOs Market by Country
6.3.2.2 Asia Pacific Bio-Pharmaceutical Companies Market by Country
6.3.2.3 Asia Pacific Contract Research Organizations (CROs) Market by Country
6.3.2.4 Asia Pacific Others Market by Country
6.3.3 Asia Pacific Microbial Fermentation Technology Market by Country
6.3.3.1 China Microbial Fermentation Technology Market
6.3.3.1.1 China Microbial Fermentation Technology Market by Application
6.3.3.1.2 China Microbial Fermentation Technology Market by End-user
6.3.3.2 Japan Microbial Fermentation Technology Market
6.3.3.2.1 Japan Microbial Fermentation Technology Market by Application
6.3.3.2.2 Japan Microbial Fermentation Technology Market by End-user
6.3.3.3 India Microbial Fermentation Technology Market
6.3.3.3.1 India Microbial Fermentation Technology Market by Application
6.3.3.3.2 India Microbial Fermentation Technology Market by End-user
6.3.3.4 South Korea Microbial Fermentation Technology Market
6.3.3.4.1 South Korea Microbial Fermentation Technology Market by Application
6.3.3.4.2 South Korea Microbial Fermentation Technology Market by End-user
6.3.3.5 Singapore Microbial Fermentation Technology Market
6.3.3.5.1 Singapore Microbial Fermentation Technology Market by Application
6.3.3.5.2 Singapore Microbial Fermentation Technology Market by End-user
6.3.3.6 Malaysia Microbial Fermentation Technology Market
6.3.3.6.1 Malaysia Microbial Fermentation Technology Market by Application
6.3.3.6.2 Malaysia Microbial Fermentation Technology Market by End-user
6.3.3.7 Rest of Asia Pacific Microbial Fermentation Technology Market
6.3.3.7.1 Rest of Asia Pacific Microbial Fermentation Technology Market by Application
6.3.3.7.2 Rest of Asia Pacific Microbial Fermentation Technology Market by End-user
6.4 LAMEA Microbial Fermentation Technology Market
6.4.1 LAMEA Microbial Fermentation Technology Market by Application
6.4.1.1 LAMEA Antibiotics Market by Country
6.4.1.2 LAMEA Recombinant Proteins Market by Country
6.4.1.3 LAMEA Enzymes Market by Country
6.4.1.4 LAMEA Monoclonal Antibodies Market by Country
6.4.1.5 LAMEA Probiotics Supplements Market by Country
6.4.1.6 LAMEA Vaccines Market by Country
6.4.1.7 LAMEA Biosimilars Market by Country
6.4.1.8 LAMEA Small Molecules Market by Country
6.4.1.9 LAMEA Others Market by Country
6.4.2 LAMEA Microbial Fermentation Technology Market by End-user
6.4.2.1 LAMEA CMOs & CDMOs Market by Country
6.4.2.2 LAMEA Bio-Pharmaceutical Companies Market by Country
6.4.2.3 LAMEA Contract Research Organizations (CROs) Market by Country
6.4.2.4 LAMEA Others Market by Country
6.4.3 LAMEA Microbial Fermentation Technology Market by Country
6.4.3.1 Brazil Microbial Fermentation Technology Market
6.4.3.1.1 Brazil Microbial Fermentation Technology Market by Application
6.4.3.1.2 Brazil Microbial Fermentation Technology Market by End-user
6.4.3.2 Argentina Microbial Fermentation Technology Market
6.4.3.2.1 Argentina Microbial Fermentation Technology Market by Application
6.4.3.2.2 Argentina Microbial Fermentation Technology Market by End-user
6.4.3.3 UAE Microbial Fermentation Technology Market
6.4.3.3.1 UAE Microbial Fermentation Technology Market by Application
6.4.3.3.2 UAE Microbial Fermentation Technology Market by End-user
6.4.3.4 Saudi Arabia Microbial Fermentation Technology Market
6.4.3.4.1 Saudi Arabia Microbial Fermentation Technology Market by Application
6.4.3.4.2 Saudi Arabia Microbial Fermentation Technology Market by End-user
6.4.3.5 South Africa Microbial Fermentation Technology Market
6.4.3.5.1 South Africa Microbial Fermentation Technology Market by Application
6.4.3.5.2 South Africa Microbial Fermentation Technology Market by End-user
6.4.3.6 Nigeria Microbial Fermentation Technology Market
6.4.3.6.1 Nigeria Microbial Fermentation Technology Market by Application
6.4.3.6.2 Nigeria Microbial Fermentation Technology Market by End-user
6.4.3.7 Rest of LAMEA Microbial Fermentation Technology Market
6.4.3.7.1 Rest of LAMEA Microbial Fermentation Technology Market by Application
6.4.3.7.2 Rest of LAMEA Microbial Fermentation Technology Market by End-user
Chapter 7. Company Profiles
7.1 Biocon Limited
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent Strategies and Developments
7.1.5.1 Acquisition and Mergers
7.2 BioVectra Inc. (H.I.G. Capital, LLC)
7.2.1 Company Overview
7.2.2 Recent Strategies and Developments
7.2.2.1 Partnerships, Collaborations, and Agreements
7.2.2.2 Product Launches and Product Expansions
7.2.2.3 Geographical Expansions
7.3 Danone S.A.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Category and Regional Analysis
7.3.4 Recent Strategies and Developments
7.3.4.1 Geographical Expansions
7.4 F. Hoffmann-La Roche Ltd.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 Koninklijke DSM N.V.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent Strategies and Developments
7.5.5.1 Acquisition, Joint Venture and Mergers
7.6 Lonza Group AG
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.7 Novozymes A/S (Novo Holdings A/S)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent Strategies and Developments
7.7.5.1 Product Launches and Product Expansions
7.8 Corbion N.V.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Bangalore Biotech Labs Pvt. Ltd. (BiOZEEN)
7.9.1 Company Overview

Companies Mentioned

  • Biocon Limited
  • BioVectra Inc. (H.I.G. Capital, LLC)
  • Danone S.A.
  • F. Hoffmann-La Roche Ltd.
  • Koninklijke DSM N.V.
  • Lonza Group AG
  • Novozymes A/S (Novo Holdings A/S)
  • Corbion N.V.
  • Bangalore Biotech Labs Pvt. Ltd. (BiOZEEN)

Methodology

Loading
LOADING...

Related Topics

Related Reports

Microbial Fermentation Technology - Global Strategic Business Report - Product Image

Microbial Fermentation Technology - Global Strategic Business Report

  • Report
  • 324 Pages
  • Global
From
Microbial Fermentation Technology Global Market Report 2024 - Product Image

Microbial Fermentation Technology Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Microbial Culture - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Microbial Culture - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 100 Pages
  • Global
From
Microbial API Global Market Report 2024 - Product Image

Microbial API Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
2024 Global Forecast for Microbial Fermentation Technology Market (2025-2030 Outlook)-High Tech & Emerging Markets Report - Product Image

2024 Global Forecast for Microbial Fermentation Technology Market (2025-2030 Outlook)-High Tech & Emerging Markets Report

  • Report
  • 132 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.